RWM
GOSS icon

Rialto Wealth Management’s Gossamer Bio GOSS Stock Holding History

Rialto Wealth Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.75K Buy
20,552
+14,800
+257% +$23.3K ﹤0.01% 528
2025
Q4 		$17.8K Sell
5,752
-5,000
-47% -$14.3K ﹤0.01% 376
2025
Q3 		$28.3K Hold
10,752
– – 0.01% 313
2025
Q2 		$13.2K Hold
10,752
– – ﹤0.01% 391
2025
Q1 		$11.8K Hold
10,752
– – ﹤0.01% 391
2024
Q4 		$9.73K Buy
+10,752
New +$9.21K ﹤0.01% 397

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Rialto Wealth Management's GOSS Position: Q1 2026 in Review

Rialto Wealth Management increased its Gossamer Bio (GOSS) stake by 257% in Q1 2026, buying an estimated $23.3K and bringing the position to 20,552 shares worth $6.75K. The position accounts for ﹤0.01% of the portfolio, ranked #528.

Rialto Wealth Management first reported a position in GOSS in Q4 2024 and has held it in 6 quarters since. The position peaked at $28.3K in Q3 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Rialto Wealth Management held 20,552 shares of Gossamer Bio worth $6.75K as of Q1 2026.
  • Rialto Wealth Management bought 14,800 Gossamer Bio shares in Q1 2026, an estimated $23.3K.
  • Gossamer Bio made up ﹤0.01% of Rialto Wealth Management's portfolio in Q1 2026, its #528 holding.
  • Rialto Wealth Management first reported a position in Gossamer Bio in Q4 2024 and has held it in 6 quarters since.
  • Rialto Wealth Management's Gossamer Bio position peaked at $28.3K in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Rialto Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.